Getinge and CellRev launch platform with potential to transform allogeneic cell therapy manufacturing
Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE (Adherent Cell Expansion). The solution, launching today, is a breakthrough within allogenic cell therapy manufacturing. “Both our companies are dedicated to helping the development of life-saving therapies gain momentum. CellRev’s technology combined with our latest bioreactor systems has the potential to transform allogeneic cell therapy manufacturing,” says Sean Herdlein, Vice President Bio-Processing at Getinge. The cell therapy market is